…and some to sell

Cambian Group Investors Chronicle

The care home operator faces a worrying debt pile, with high interest rates. It’s considering selling assets to deleverage, but, given NHS funding issues, the market is in “choppy waters”, with no recovery in sight. Sell. 90p.

French Connection Investors Chronicle

The fashion retailer saw promising UK and European sales, but margins were flat, and the wholesale division performed poorly. There’s insufficient evidence of a tangible turnaround to turn bullish. Sell. 37.75p.

Kingfisher The Mail on Sunday

Revenues at the B&Q owner were ahead of expectations, but Haitong Research fears the scale of the transformation needed. Sales in Russia and Turkey disappointed, and market conditions in France are tough. Sell. 283.5p.

Majestic Wine Investors Chronicle

Wine retailer Majestic’s UK retail sales are doing well and it should resume dividends. But shares collapsed 26% after it warned of a slump in commercial sales, and there’s no clear indication of a reversal. Sell. 330p.

Millennium & Copthorne Hotels Investors Chronicle

Hotel group M&C is suffering declining revenues per room, and is due to enter a period of construction and refurbishment that will mean negative free cash flow. The dividend is under review. Sell. 436p.

Oxford Biomedica London Evening Standard

The gene therapy firm is raising £10m and has announced a tie-up with Novartis to give “significant commercial opportunity”. But N+1 Singer is concerned about the pharma’s long-term commitment to cell therapy. Sell. 4.2p.